Quantcast
Home » Topics » Gilead

AIDS drugs can prevent infection, two studies show

LONDON (Reuters) – AIDS drugs used to treat HIV can also be used to prevent infection among heterosexual men and women, according to the results of two studies conducted in Africa released on Wednesday. The findings add to growing evidence that drugs used since the mid-1990s to treat people who…

Licensing deal to boost HIV drug access

US pharmaceutical giant Gilead Sciences and an NGO called the Medicines Patent Pool announced a deal on Tuesday aimed at boosting access to HIV drugs in poorer countries through generic manufacturing. The HIV medicines tenofovir and emtricitabine, as well as two drugs that are still in clinical development, cobicistat and…

Google+